125 related articles for article (PubMed ID: 36789959)
1. The lasting impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study.
Taylor R; Khan A; Omakobia E; Sood S
J Laryngol Otol; 2023 May; 137(5):537-540. PubMed ID: 36789959
[TBL] [Abstract][Full Text] [Related]
2. The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study.
Taylor R; Omakobia E; Sood S; Glore RJ
J Laryngol Otol; 2020 Aug; 134(8):684-687. PubMed ID: 32758307
[TBL] [Abstract][Full Text] [Related]
3. The impact of coronavirus disease 2019 on suspected head and neck cancer two-week-wait referrals.
Bhamra N; Gorman B; Arnold W; Rajah A; Jolly K; Nieto H; Fussey J; Liew L
J Laryngol Otol; 2022 Mar; 136(3):248-251. PubMed ID: 34158135
[TBL] [Abstract][Full Text] [Related]
4. Impact of coronavirus disease 2019 on head and neck urgent suspected cancer referral pathways in rural Wales.
Abelardo E; Gravelle R; Scannell M; Shastri P; Vandekar M; Davies G; Volpini L; Prabhu V
J Laryngol Otol; 2022 Jun; 136(6):540-546. PubMed ID: 35357276
[TBL] [Abstract][Full Text] [Related]
5. Telephone triage of suspected head and neck cancer patients during the coronavirus disease 2019 pandemic using the Head and Neck Cancer Risk Calculator version 2.
Banerjee S; Voliotidis D; Parvin L; Rama SPK
J Laryngol Otol; 2021 Mar; 135(3):241-245. PubMed ID: 33648611
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease 2019 pandemic telephone two-week-wait referrals in head and neck cancer - how safe were they?
Lau KL; Wilson M; Oozeer N; Cocks H
J Laryngol Otol; 2024 Mar; 138(3):321-324. PubMed ID: 37403606
[TBL] [Abstract][Full Text] [Related]
7. The impact of coronavirus disease 2019 on the head and neck cancer pathway in the West of Scotland.
Drake I; Rogers A; Stewart M; Montgomery J
J Laryngol Otol; 2022 Jun; 136(6):535-539. PubMed ID: 35225177
[TBL] [Abstract][Full Text] [Related]
8. Primary care triaging of head and neck cancer referrals using the head and neck cancer risk calculator version 2: impact on a tertiary head and neck service.
Li L; Tikka T; Morton C; Chan C; Hayois L; Henderson M; Hastie C; Lee L; Porteus L; Nixon I
J Laryngol Otol; 2023 Jul; 137(7):763-768. PubMed ID: 35995755
[TBL] [Abstract][Full Text] [Related]
9. Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
Hardman JC; Tikka T; Paleri V;
Cancer; 2021 Nov; 127(22):4177-4189. PubMed ID: 34411287
[TBL] [Abstract][Full Text] [Related]
10. Head and neck cancer surgery during the coronavirus pandemic: a single-institution experience.
Jeannon JP; Simo R; Oakley R; Townley W; Orfaniotis G; Fry A; Arora A; Taylor C; Ahmad I
J Laryngol Otol; 2021 Feb; 135(2):168-172. PubMed ID: 33517925
[TBL] [Abstract][Full Text] [Related]
11. Outcomes for patients referred urgently with suspected head and neck cancer.
Hobson JC; Malla JV; Sinha J; Kay NJ; Ramamurthy L
J Laryngol Otol; 2008 Nov; 122(11):1241-4. PubMed ID: 18371234
[TBL] [Abstract][Full Text] [Related]
12. Impact of primary care triage using the Head and Neck Cancer Risk Calculator version 2 on tertiary head and neck services in the post-coronavirus disease 2019 period.
Tan JY; Callaghan CJ; Lewthwaite AW; Chan CCH; Wee CT; To EYH; Summers I; Nelson JW; Smith MB; Li LQ; Morton C; Porteous L; Evans AS; Nixon IJ
J Laryngol Otol; 2024 Jan; ():1-6. PubMed ID: 38250823
[TBL] [Abstract][Full Text] [Related]
13. Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic.
Kaddour H; Jama GM; Stagnell S; Kaddour S; Guner K; Kumar G
Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):1111-1115. PubMed ID: 34661717
[TBL] [Abstract][Full Text] [Related]
14. Outcome of two-week head and neck cancer pathway for the otolaryngology department in a tertiary centre.
Mettias B; Charlton A; Ashokkumar S
J Laryngol Otol; 2021 Oct; 135(10):869-873. PubMed ID: 34348805
[TBL] [Abstract][Full Text] [Related]
15. North East London coronavirus disease 2019 protocol for diagnostics in two-week wait head and neck cancer patients.
Warner E; Scholfield DW; Adams A; Richards P; Ali S; Ahmed J; Ghufoor K
J Laryngol Otol; 2020 Aug; 134(8):680-683. PubMed ID: 32613916
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 pandemic on head-neck cancer referral and treatment pathway in North East London.
Zubair A; Jamshaid S; Scholfield DW; Hariri AA; Ahmed J; Ghufoor K; Ali S
Ann R Coll Surg Engl; 2023 Aug; 105(S2):S28-S34. PubMed ID: 35446702
[TBL] [Abstract][Full Text] [Related]
17. Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services.
Abou-Foul AK; Ross E; Abou-Foul M; George AP
J Laryngol Otol; 2021 Nov; 135(11):1025-1030. PubMed ID: 34526175
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of urgent suspicion of head and neck cancer referrals in Glasgow.
Douglas CM; Carswell V; Montgomery J
Ann R Coll Surg Engl; 2019 Feb; 101(2):103-106. PubMed ID: 30372125
[TBL] [Abstract][Full Text] [Related]
19. A novel remote assessment pathway to streamline the management of two-week-wait suspected head and neck cancer referrals: a prospective analysis of 660 patients.
Metcalfe C; Oh S; Glazzard N; Ross E; George A
J Laryngol Otol; 2024 Jun; 138(6):667-671. PubMed ID: 38369910
[TBL] [Abstract][Full Text] [Related]
20. Advancing head and neck cancer following the coronavirus disease 2019 pandemic.
Flynn W; Maqsood R; Maseland T; Montgomery J; Douglas C
J Laryngol Otol; 2022 Nov; 136(11):1118-1124. PubMed ID: 35445646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
